Professional
Added to YB: 2025-11-21
Pitch date: 2025-11-19
ELVA [neutral]
Electrovaya Inc.
+40.72%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Electrovaya Inc. engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America.
Market Cap
CAD 220.1M
Pitch Price
CAD 6.41
Price Target
N/A
Dividend
N/A
EV/EBITDA
45.86
P/E
169.22
EV/Sales
4.37
Sector
Electrical Equipment
Category
growth
Pernas Research Passes On: Electrovaya Inc.
ELVA (pass): Clinical biotech using AI/automation for drug discovery, reducing target-to-preclinical timeline from 40 to 18 months via Recursion OS analyzing billions of cell experiments. $330M net loss on $45M revenue. Mixed efficacy results, awaiting proof AI approach works.
Read full article (1 min)